Viewing StudyNCT00239252



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00239252
Status: COMPLETED
Last Update Posted: 2014-08-26
First Post: 2005-09-13

Brief Title: Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Hepatitis C
Keywords:
Name View
Interferon alfacon-1 View
Virus disease View
Hepatitis C View